Pseudogene KRT17P3 drives cisplatin resistance of human NSCLC cells by modulating miR‐497‐5p/mTOR

Chemoresistance is a major obstacle in non–small cell lung cancer (NSCLC) treatment. The pseudogene keratin 17 pseudogene 3 (KRT17P3) has been previously shown to be upregulated in lung cancer tissues of patients with cisplatin resistance. In the present study, RT‐qPCR was performed to evaluate KRT1...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Zhibo, Wang, Yi, Xia, Ning, Lv, Tangfeng, Yuan, Xiaoqin, Song, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Cell, Molecular, and Stem Cell Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780050/
https://www.ncbi.nlm.nih.gov/pubmed/33179318
http://dx.doi.org/10.1111/cas.14733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780050/
https://www.ncbi.nlm.nih.gov/pubmed/33179318
http://dx.doi.org/10.1111/cas.14733

Ejemplares similares